Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Priel

Showing results (401-410 of 433) with videos related to

Pageof 44
Sort By:
Blood Advances|August 8, 2022
Surgical outcomes in people with hemophilia A taking emicizumab prophylaxis: experience from the HAVEN 1-4 studiesRebecca Kruse-Jarres, Flora Peyvandi, Johannes Oldenburg, et al.
Blood|September 6, 2011
The CXCR4 antagonist plerixafor corrects panleukopenia in patients with WHIM syndromeDavid H McDermott, Qian Liu, Jean Ulrick, et al.
Blood|July 10, 2010
Severe congenital neutropenia resulting from G6PC3 deficiency with increased neutrophil CXCR4 expression and myelokathexisDavid H McDermott, Suk See De Ravin, Hyun Sik Jun, et al.
Circulation|September 21, 2014
Assessment of atherosclerosis in chronic granulomatous diseaseChristopher T Sibley, Tyra Estwick, Anna Zavodni, et al.
Blood|January 29, 2021
Long-term outcomes with emicizumab prophylaxis for hemophilia A with or without FVIII inhibitors from the HAVEN 1-4 studiesMichael U Callaghan, Claude Negrier, Ido Paz-Priel, et al.
American Journal of Human Genetics|September 25, 2012
A hypermorphic missense mutation in PLCG2, encoding phospholipase Cγ2, causes a dominantly inherited autoinflammatory disease with immunodeficiencyQing Zhou, Geun-Shik Lee, Jillian Brady, et al.
Nature Communications|September 27, 2019
Human PI3Kγ deficiency and its microbiota-dependent mouse model reveal immunodeficiency and tissue immunopathologyAndrew J Takeda, Timothy J Maher, Yu Zhang, et al.
Clinical Pharmacology and Therapeutics|January 20, 2023
Mitigating Drug-Target-Drug Complexes in Patients With Paroxysmal Nocturnal Hemoglobinuria Who Switch C5 InhibitorsJun-Ichi Nishimura, Antoine Soubret, Noriko Arase, et al.
The Journal of Allergy and Clinical Immunology|May 22, 2017
X-linked carriers of chronic granulomatous disease: Illness, lyonization, and stabilityBeatriz E Marciano, Christa S Zerbe, E Liana Falcone, et al.
Blood|August 26, 2016
Cytoskeletal abnormalities and neutrophil dysfunction in WDR1 deficiencyDouglas B Kuhns, Danielle L Fink, Uimook Choi, et al.
Pageof 44

Showing results (401-410 of 433) with videos related to

Sort By:
Pageof 44
Blood Advances|August 8, 2022
Surgical outcomes in people with hemophilia A taking emicizumab prophylaxis: experience from the HAVEN 1-4 studiesRebecca Kruse-Jarres, Flora Peyvandi, Johannes Oldenburg, et al.
Blood|September 6, 2011
The CXCR4 antagonist plerixafor corrects panleukopenia in patients with WHIM syndromeDavid H McDermott, Qian Liu, Jean Ulrick, et al.
Blood|July 10, 2010
Severe congenital neutropenia resulting from G6PC3 deficiency with increased neutrophil CXCR4 expression and myelokathexisDavid H McDermott, Suk See De Ravin, Hyun Sik Jun, et al.
Circulation|September 21, 2014
Assessment of atherosclerosis in chronic granulomatous diseaseChristopher T Sibley, Tyra Estwick, Anna Zavodni, et al.
Blood|January 29, 2021
Long-term outcomes with emicizumab prophylaxis for hemophilia A with or without FVIII inhibitors from the HAVEN 1-4 studiesMichael U Callaghan, Claude Negrier, Ido Paz-Priel, et al.
American Journal of Human Genetics|September 25, 2012
A hypermorphic missense mutation in PLCG2, encoding phospholipase Cγ2, causes a dominantly inherited autoinflammatory disease with immunodeficiencyQing Zhou, Geun-Shik Lee, Jillian Brady, et al.
Nature Communications|September 27, 2019
Human PI3Kγ deficiency and its microbiota-dependent mouse model reveal immunodeficiency and tissue immunopathologyAndrew J Takeda, Timothy J Maher, Yu Zhang, et al.
Clinical Pharmacology and Therapeutics|January 20, 2023
Mitigating Drug-Target-Drug Complexes in Patients With Paroxysmal Nocturnal Hemoglobinuria Who Switch C5 InhibitorsJun-Ichi Nishimura, Antoine Soubret, Noriko Arase, et al.
The Journal of Allergy and Clinical Immunology|May 22, 2017
X-linked carriers of chronic granulomatous disease: Illness, lyonization, and stabilityBeatriz E Marciano, Christa S Zerbe, E Liana Falcone, et al.
Blood|August 26, 2016
Cytoskeletal abnormalities and neutrophil dysfunction in WDR1 deficiencyDouglas B Kuhns, Danielle L Fink, Uimook Choi, et al.
Pageof 44